Conference abstract · 16 Mar 2021
Conference abstractPublished 2017
Using nanocarriers against synucleinopathies
National Institute of Genetic Engineering and Biotechnology, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
α-Synuclein (α-Syn) is a protein present in the brains of a range of neurodegenerative disordered patients as plaque-like compact structures in the form of amyloid fibrils. There is a strong relationship between α-Syn amyloid fibrillation and the pathology of the neurodegenerative disorders such as Parkinson’s disease. There is a serious effort to apply the compounds, known as small molecules, with inhibitory effects on the different steps of α-SN fibrillation and its related neurotoxicity. However, the small molecules can possess some problems like high hydrophobicity/low solubility in physiological fluids, instability, and difficulty in passing across blood brain barrier (BBB). In this respect, employing of nanocarriers has been pointed because of a lot of advantages i.e., biocompatibility, easy surface modification, low immunogenicity, protecting cargo against enzymatic degradation. In this regard, we used three different nanocarriers including serum albumin nanoparticles (SA- NPs), mesoporous silica nanoparticles (MS-NPs) and neutral charged nanoliposomes (NC-NLPs). We found that each kind of nanocarrier possess specific characters when applying for loading drugs or treating α-Syn or neuronal cells. SA-NPs with a moderate drug loading efficiency (DLE) for polyphenols, showed some inducing effect on α-Syn fibrillation when treating with bare SA-NPs. Although MS-NPs with similar DLE did not show inducing effect on α-Syn fibrillation, they had a small neurotoxicity effect. On the other hand, NC-NLPs had high DLE for polyphenols and also, they did not indicate any considerable induction on the α-Syn fibrillation or any neurotoxicity effects. It seems that NC-NLPs have more potential for using regarding synucleinopathies treating than the two other NPs.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 13 Mar 2024
Driving Precision Medicine: The Molecular Engineering of Nanocarriers for Targeted Drug Delivery
Conference abstract · 2021
Combined formulation of doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGAencapsulated nanocarrier improves anti-tumor activity
Conference abstract · 2021
Magnetotherapy in support of targeted anti-cancer therapies based on the application of magnetoliposomes as nanocarriers of anti-cancer drugs
Conference abstract · 2021
Nanocarriers in the immune regulation
More from this journal
The newest in Journal of Nanomaterials & Molecular Nanotechnology.
Mini review · 24 Feb 2025
The Synthesis and Doping of Plant-Mediated Tin Oxide Nanoparticles and Its Applications
Short communication · 24 Dec 2024
Role of Nanomaterials in Environmental Remediation: Pollution Control and Water Purification
Opinion · 24 Dec 2024
Innovations in Nanomaterials: Connection between Research and Industry
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomaterials & Molecular Nanotechnology
- SubjectNanotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “D Morshedi”

